High‐Throughput Engineering and Modification of Non‐Ribosomal Peptide Synthetases Based on Golden Gate Assembly
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202508967 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Adrian Podolski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Products in Organismic Interactions, Max Planck Institute for Terrestrial Microbiology, 35043, Marburg, Germany. Hauptthemen laut MEDLINE: Peptide Synthases, Protein Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 European Research Council.
Abstract (Originalsprache)
Non‐ribosomal peptide synthetases (NRPS) are multimodular enzymes that produce complex peptides with diverse biological activities, potentially being used as clinical drugs. However, the pharmaceutical applications of such natural peptides often require further derivatisation and modification of the peptide backbone, mainly performed by chemical synthesis. A sustainable alternative resembles the in vivo engineering of NRPS to change and modify the enzyme properties rationally and, thus, the produced products. The novel NRPS engineering approach, the eXchange Unit Thiolation domain (XUT) concept, allows the efficient modular assembly of different natural NRPS fragments to form hybrid NRPS that produce defined peptides. In this study, we describe a Golden Gate Assembly (GGA)‐based method for efficient high‐throughput generation of novel and engineered NRPS libraries utilising the XUT concept. This method was applied to generate over 100 novel NRPS with the possibility of changing starter, elongation, and termination modules, respectively. Additionally, we applied this method for targeted modification of the xenoamicin biosynthetic gene cluster (BGC) xabABCD from Xenorhabdus doucetiae , resulting in the generation of 25 novel xenoamicin derivatives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Natural Products in Organismic Interactions, Max Planck Institute for Terrestrial Microbiology, 35043, Marburg, Germany.
- Molecular Biotechnology, Department of Biosciences, Goethe University Frankfurt, 60438, Frankfurt am Main, Germany.
- MaxGENESYS Biofoundry, Max Planck Institute for Terrestrial Microbiology, 35043, Marburg, Germany.
- Myria Biosciences AG, Hochbergerstrasse 60 C, Basel, 4057, Switzerland.
- Center for Synthetic Microbiology (SYNMIKRO), Phillips University Marburg, 35043, Marburg, Germany.
- Department of Chemistry, Phillips University Marburg, 35043, Marburg, Germany.
ORCID-Profile: Helge B Bode
Förderung
- H2020 European Research Council
Zitieren
APA
Podolski, A., Lindeboom, T. A., Präve, L., Dehghan, M., Minas, H. A., Kranz, J., Schindler, D., & Bode, H. B. (2025). High‐Throughput Engineering and Modification of Non‐Ribosomal Peptide Synthetases Based on Golden Gate Assembly. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202508967
Vancouver
Podolski A, Lindeboom TA, Präve L, Dehghan M, Minas HA, Kranz J, et al. High‐Throughput Engineering and Modification of Non‐Ribosomal Peptide Synthetases Based on Golden Gate Assembly. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202508967
BibTeX
@article{Podolski2025,
author = {Podolski, Adrian and Lindeboom, Timon A and Präve, Leonard and Dehghan, Maryam and Minas, Hannah A and Kranz, Janik and Schindler, Daniel and Bode, Helge B},
title = {High‐Throughput Engineering and Modification of Non‐Ribosomal Peptide Synthetases Based on Golden Gate Assembly},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202508967}
}
EUVIMED